..

ஜர்னல் ஆஃப் இன்டகிரேடிவ் ஆன்காலஜி

ஐ.எஸ்.எஸ்.என்: 2329-6771

திறந்த அணுகல்
கையெழுத்துப் பிரதியை சமர்ப்பிக்கவும் arrow_forward arrow_forward ..

Cellular Oncology and Precision Medicine: Targeted Therapies for Cancer Treatment

Abstract

Chaong Wang*

Plasma is a component of blood that contains water, electrolytes, hormones, waste products, and proteins, including antibodies and clotting factors. While plasma itself is not used as a primary treatment for cancer, it does play a vital role in cancer care in several ways. Cancer patients undergoing treatments like chemotherapy and radiation therapy may experience a decrease in their blood cell counts, including red blood cells (anaemia) and platelets (thrombocytopenia). In such cases, patients may require blood transfusions, which can include components like plasma to help manage these side effects. Cancer is a major public health problem worldwide. Global demographic characteristics predict an increasing cancer incidence in the next decades, with >20 million new cancer cases annually expected by 2025. According to GLOBOCAN data, 14.1 million new cases and 8.2 million deaths from cancer were estimated in 2012.1 Cancers of the female breast, colorectal, prostate, and lung are the most frequently diagnosed cancers in Europe.2 Lung cancer remains the leading cause of cancer incidence and mortality worldwide.

மறுப்பு: இந்த சுருக்கமானது செயற்கை நுண்ணறிவு கருவிகளைப் பயன்படுத்தி மொழிபெயர்க்கப்பட்டது மற்றும் இன்னும் மதிப்பாய்வு செய்யப்படவில்லை அல்லது சரிபார்க்கப்படவில்லை

இந்தக் கட்டுரையைப் பகிரவும்

குறியிடப்பட்டது

arrow_upward arrow_upward